Total Clearance Sale

Axon Labs is selling all our remaining inventory.

Over the past several months, it has become increasingly difficult for us to process payments made by customers, because -- as strange as it sounds -- the banks that receive credit and debit card payments have become increasingly scared about nootropics, despite the legal status of most compounds considered "nootropics" in most jurisdictions.  A lot of this seems to trace back to the 2016 United Kingdom Psychoactive Substances Act, which was created to combat street drugs (not nootropics), but took a guilty until proven innocent approach in doing so.

The ripple effects seem to have far exceeded this law's actual legal jurisdiction, and over the course of 2017, Axon Labs experienced:

Axon Labs is not alone in these difficulties.

There is an industry-wide "guilt by association" complex affecting products featuring compounds like the racetams.  The situation seems to be encouraging business extremes rather than a middle path: either extremely well-known ingredients perceived to be un-risky (e.g. Vitamin C) or extremely underground, illegal sales structures (e.g. prescription-only pharmaceuticals sold from international sources and paid with money-laundering tactics).

Axon Labs has been described by banks -- including our current banks -- as having "reputational risk."  This makes us bristle.  But while it's galling to walk away from a fight, we also believe in picking our battles.

As of now, Nexus is on a major clearance sale. We're selling until the shelves are empty.  (Mitogen has sold out already.)

Thanks again, so much, for your patronage.

- the Axon Labs Team